U.S. Drug Companies Chase Vaccines

Amid rising concern about the threat of influenza pandemics, three big drug makers announced deals Monday that give them rights to new flu vaccines, placing bets on one of the pharmaceutical industry's brightest, but riskiest, segments.

The deals reflect the growing conviction among pharmaceutical executives that vaccines against a variety of maladies, long an industry stepchild, will...